# Tier 5 Enumeration: Neurological & Psychiatric Medications

> **Location in Hierarchy**:
> Tier 1: Medical > Tier 2: Medications > Tier 3: Prescription Medications > Tier 4: Neurological/Psychiatric Medications > **Tier 5: Individual Cards**

---

## Overview

This document enumerates ALL individual Tier 5 cards for Neurological and Psychiatric Medications. Each entry represents ONE SMART card with titratable doses handled within a single card.

**Total Estimated Cards**: ~100 cards

---

## ANTIDEPRESSANTS

### Tier 4: SSRIs (Selective Serotonin Reuptake Inhibitors)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_SSRI_001 | Sertraline (Zoloft) | 25-200mg daily | MDD, Anxiety, OCD, PTSD, PMDD |
| MED_NEURO_SSRI_002 | Escitalopram (Lexapro) | 5-20mg daily | MDD, GAD |
| MED_NEURO_SSRI_003 | Fluoxetine (Prozac) | 10-80mg daily | MDD, OCD, Bulimia, Panic, PMDD |
| MED_NEURO_SSRI_004 | Paroxetine (Paxil) | 10-60mg daily | MDD, GAD, Panic, OCD, PTSD, SAD |
| MED_NEURO_SSRI_005 | Citalopram (Celexa) | 10-40mg daily | MDD (max 40mg due to QT) |
| MED_NEURO_SSRI_006 | Fluvoxamine (Luvox) | 50-300mg daily | OCD, SAD |
| MED_NEURO_SSRI_007 | Vilazodone (Viibryd) | 10-40mg daily | MDD (SSRI + 5-HT1A partial) |
| MED_NEURO_SSRI_008 | Vortioxetine (Trintellix) | 5-20mg daily | MDD (multimodal) |

**Subtotal: 8 cards**

---

### Tier 4: SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_SNRI_001 | Duloxetine (Cymbalta) | 30-120mg daily | MDD, GAD, Neuropathy, Fibromyalgia |
| MED_NEURO_SNRI_002 | Venlafaxine XR (Effexor XR) | 37.5-225mg daily | MDD, GAD, Panic, SAD |
| MED_NEURO_SNRI_003 | Desvenlafaxine (Pristiq) | 50-100mg daily | MDD |
| MED_NEURO_SNRI_004 | Levomilnacipran (Fetzima) | 20-120mg daily | MDD |
| MED_NEURO_SNRI_005 | Milnacipran (Savella) | 50-100mg BID | Fibromyalgia |

**Subtotal: 5 cards**

---

### Tier 4: Atypical Antidepressants

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_ATYP_001 | Bupropion SR/XL (Wellbutrin) | 150-450mg daily | MDD, Smoking cessation, ADHD |
| MED_NEURO_ATYP_002 | Mirtazapine (Remeron) | 15-45mg HS | MDD (sedating, appetite stimulant) |
| MED_NEURO_ATYP_003 | Trazodone | 50-300mg HS | MDD, Insomnia |
| MED_NEURO_ATYP_004 | Nefazodone | 200-600mg daily (divided) | MDD (hepatotoxicity warning) |

**Subtotal: 4 cards**

---

### Tier 4: Tricyclic Antidepressants (TCAs)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_TCA_001 | Amitriptyline (Elavil) | 25-150mg HS | MDD, Neuropathy, Migraine prophylaxis |
| MED_NEURO_TCA_002 | Nortriptyline (Pamelor) | 25-150mg daily | MDD, Neuropathy (less sedating TCA) |
| MED_NEURO_TCA_003 | Desipramine (Norpramin) | 100-300mg daily | MDD (least anticholinergic TCA) |
| MED_NEURO_TCA_004 | Imipramine (Tofranil) | 75-200mg daily | MDD, Enuresis, Panic |
| MED_NEURO_TCA_005 | Doxepin (Sinequan) | 25-300mg daily | MDD, Insomnia (low-dose), Urticaria |
| MED_NEURO_TCA_006 | Clomipramine (Anafranil) | 25-250mg daily | OCD (most serotonergic TCA) |

**Subtotal: 6 cards**

---

### Tier 4: MAOIs (Monoamine Oxidase Inhibitors)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_MAOI_001 | Phenelzine (Nardil) | 15-90mg daily (divided) | Treatment-resistant depression |
| MED_NEURO_MAOI_002 | Tranylcypromine (Parnate) | 10-60mg daily (divided) | Treatment-resistant depression |
| MED_NEURO_MAOI_003 | Selegiline Patch (Emsam) | 6-12mg/24hr patch | MDD (transdermal, less diet restriction) |

**Subtotal: 3 cards**

---

## ANXIOLYTICS

### Tier 4: Benzodiazepines

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_BENZO_001 | Lorazepam (Ativan) | 0.5-2mg BID-TID | Anxiety, Insomnia, Seizures, Alcohol WD |
| MED_NEURO_BENZO_002 | Alprazolam (Xanax) | 0.25-1mg TID | Panic, GAD |
| MED_NEURO_BENZO_003 | Clonazepam (Klonopin) | 0.25-2mg BID | Panic, Seizures, Anxiety |
| MED_NEURO_BENZO_004 | Diazepam (Valium) | 2-10mg BID-QID | Anxiety, Muscle spasm, Seizures, Alcohol WD |
| MED_NEURO_BENZO_005 | Chlordiazepoxide (Librium) | 25-100mg TID-QID | Alcohol withdrawal |
| MED_NEURO_BENZO_006 | Oxazepam (Serax) | 10-30mg TID-QID | Anxiety (safer in liver disease) |
| MED_NEURO_BENZO_007 | Temazepam (Restoril) | 7.5-30mg HS | Insomnia |
| MED_NEURO_BENZO_008 | Triazolam (Halcion) | 0.125-0.25mg HS | Insomnia (ultra-short) |

**Subtotal: 8 cards**

---

### Tier 4: Non-Benzodiazepine Anxiolytics

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_ANXOTH_001 | Buspirone (Buspar) | 5-30mg BID | GAD (non-addictive) |
| MED_NEURO_ANXOTH_002 | Hydroxyzine (Vistaril) | 25-100mg QID | Anxiety, Pruritus, Sedation |

**Subtotal: 2 cards**

---

## ANTIPSYCHOTICS

### Tier 4: Second-Generation (Atypical) Antipsychotics

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_SGA_001 | Quetiapine (Seroquel) | 25-800mg daily | Schizophrenia, Bipolar, MDD augment, Insomnia |
| MED_NEURO_SGA_002 | Risperidone (Risperdal) | 0.5-8mg daily | Schizophrenia, Bipolar, Irritability in ASD |
| MED_NEURO_SGA_003 | Olanzapine (Zyprexa) | 2.5-20mg daily | Schizophrenia, Bipolar (metabolic risk) |
| MED_NEURO_SGA_004 | Aripiprazole (Abilify) | 2-30mg daily | Schizophrenia, Bipolar, MDD augment, Tourette's |
| MED_NEURO_SGA_005 | Ziprasidone (Geodon) | 20-80mg BID (with food) | Schizophrenia, Bipolar (QT risk) |
| MED_NEURO_SGA_006 | Paliperidone (Invega) | 3-12mg daily | Schizophrenia (active metabolite of risperidone) |
| MED_NEURO_SGA_007 | Lurasidone (Latuda) | 20-160mg daily (with food) | Schizophrenia, Bipolar depression |
| MED_NEURO_SGA_008 | Asenapine (Saphris) | 5-10mg BID SL | Schizophrenia, Bipolar |
| MED_NEURO_SGA_009 | Iloperidone (Fanapt) | 6-12mg BID | Schizophrenia |
| MED_NEURO_SGA_010 | Brexpiprazole (Rexulti) | 0.5-3mg daily | Schizophrenia, MDD augment |
| MED_NEURO_SGA_011 | Cariprazine (Vraylar) | 1.5-6mg daily | Schizophrenia, Bipolar |
| MED_NEURO_SGA_012 | Clozapine (Clozaril) | 12.5-900mg daily | Treatment-resistant schizophrenia (ANC monitoring) |
| MED_NEURO_SGA_013 | Pimavanserin (Nuplazid) | 34mg daily | Parkinson's psychosis |

**Subtotal: 13 cards**

---

### Tier 4: First-Generation (Typical) Antipsychotics

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_FGA_001 | Haloperidol (Haldol) | 0.5-20mg daily | Schizophrenia, Acute agitation, Tourette's |
| MED_NEURO_FGA_002 | Perphenazine (Trilafon) | 8-64mg daily | Schizophrenia |
| MED_NEURO_FGA_003 | Fluphenazine (Prolixin) | 1-20mg daily | Schizophrenia |
| MED_NEURO_FGA_004 | Chlorpromazine (Thorazine) | 25-800mg daily | Schizophrenia, N/V, Hiccups |
| MED_NEURO_FGA_005 | Thiothixene (Navane) | 5-60mg daily | Schizophrenia |

**Subtotal: 5 cards**

---

## MOOD STABILIZERS

### Tier 4: Lithium & Other Mood Stabilizers

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_MOOD_001 | Lithium (Lithobid, Eskalith) | 600-1800mg daily (level-guided) | Bipolar disorder |

**Subtotal: 1 card**

---

## ANTI-SEIZURE MEDICATIONS

### Tier 4: Traditional Anticonvulsants

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_AED_001 | Valproic Acid/Divalproex (Depakote) | 500-2500mg daily | Epilepsy, Bipolar, Migraine |
| MED_NEURO_AED_002 | Carbamazepine (Tegretol) | 400-1600mg daily | Epilepsy, Trigeminal neuralgia, Bipolar |
| MED_NEURO_AED_003 | Phenytoin (Dilantin) | 200-400mg daily | Epilepsy |
| MED_NEURO_AED_004 | Phenobarbital | 60-200mg daily | Epilepsy, Sedation, Neonatal seizures |
| MED_NEURO_AED_005 | Primidone (Mysoline) | 250-1500mg daily | Epilepsy, Essential tremor |

**Subtotal: 5 cards**

---

### Tier 4: Newer Anticonvulsants

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_AEDN_001 | Levetiracetam (Keppra) | 500-3000mg daily (BID) | Epilepsy (broad-spectrum) |
| MED_NEURO_AEDN_002 | Lamotrigine (Lamictal) | 25-400mg daily | Epilepsy, Bipolar maintenance |
| MED_NEURO_AEDN_003 | Topiramate (Topamax) | 100-400mg daily | Epilepsy, Migraine, Weight loss |
| MED_NEURO_AEDN_004 | Oxcarbazepine (Trileptal) | 600-2400mg daily (BID) | Epilepsy |
| MED_NEURO_AEDN_005 | Gabapentin (Neurontin) | 300-3600mg daily (TID) | Epilepsy, Neuropathy, Anxiety, RLS |
| MED_NEURO_AEDN_006 | Pregabalin (Lyrica) | 75-600mg daily (BID-TID) | Epilepsy, Neuropathy, Fibromyalgia, Anxiety |
| MED_NEURO_AEDN_007 | Zonisamide (Zonegran) | 100-600mg daily | Epilepsy |
| MED_NEURO_AEDN_008 | Lacosamide (Vimpat) | 100-400mg daily (BID) | Epilepsy (partial-onset) |
| MED_NEURO_AEDN_009 | Brivaracetam (Briviact) | 50-200mg daily (BID) | Epilepsy |
| MED_NEURO_AEDN_010 | Perampanel (Fycompa) | 4-12mg HS | Epilepsy (partial, tonic-clonic) |
| MED_NEURO_AEDN_011 | Clobazam (Onfi) | 5-40mg daily | Lennox-Gastaut syndrome |
| MED_NEURO_AEDN_012 | Eslicarbazepine (Aptiom) | 400-1600mg daily | Epilepsy (partial-onset) |

**Subtotal: 12 cards**

---

## MIGRAINE MEDICATIONS

### Tier 4: Acute Migraine - Triptans

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_TRIP_001 | Sumatriptan (Imitrex) | 25-100mg PO, 6mg SQ, 5-20mg nasal | Acute migraine |
| MED_NEURO_TRIP_002 | Rizatriptan (Maxalt) | 5-10mg PO (MLT available) | Acute migraine |
| MED_NEURO_TRIP_003 | Zolmitriptan (Zomig) | 2.5-5mg PO/nasal | Acute migraine |
| MED_NEURO_TRIP_004 | Eletriptan (Relpax) | 20-40mg PO | Acute migraine |
| MED_NEURO_TRIP_005 | Almotriptan (Axert) | 6.25-12.5mg PO | Acute migraine |
| MED_NEURO_TRIP_006 | Naratriptan (Amerge) | 1-2.5mg PO | Acute migraine (long half-life) |
| MED_NEURO_TRIP_007 | Frovatriptan (Frova) | 2.5mg PO | Acute migraine, Menstrual migraine |

**Subtotal: 7 cards**

---

### Tier 4: Acute Migraine - Non-Triptans

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_MIGAC_001 | Ubrogepant (Ubrelvy) | 50-100mg PRN | Acute migraine (CGRP antagonist) |
| MED_NEURO_MIGAC_002 | Rimegepant (Nurtec) | 75mg PRN | Acute migraine (also preventive) |
| MED_NEURO_MIGAC_003 | Lasmiditan (Reyvow) | 50-200mg PRN | Acute migraine (5-HT1F, no vasoconstriction) |
| MED_NEURO_MIGAC_004 | Dihydroergotamine (Migranal) | 1 spray each nostril, repeat x1 | Acute migraine (ergot) |
| MED_NEURO_MIGAC_005 | Ergotamine/Caffeine (Cafergot) | 1-2mg PO PRN | Acute migraine (ergot) |

**Subtotal: 5 cards**

---

### Tier 4: Migraine Prevention - CGRP Inhibitors

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_CGRP_001 | Erenumab (Aimovig) | 70-140mg SQ monthly | Migraine prevention |
| MED_NEURO_CGRP_002 | Fremanezumab (Ajovy) | 225mg SQ monthly or 675mg quarterly | Migraine prevention |
| MED_NEURO_CGRP_003 | Galcanezumab (Emgality) | 240mg load, then 120mg SQ monthly | Migraine prevention, Cluster HA |
| MED_NEURO_CGRP_004 | Eptinezumab (Vyepti) | 100-300mg IV q3months | Migraine prevention |
| MED_NEURO_CGRP_005 | Atogepant (Qulipta) | 10-60mg daily | Migraine prevention (oral) |

**Subtotal: 5 cards**

---

## ADHD MEDICATIONS

### Tier 4: Stimulants

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_STIM_001 | Methylphenidate IR (Ritalin) | 5-60mg daily (BID-TID) | ADHD |
| MED_NEURO_STIM_002 | Methylphenidate ER (Concerta) | 18-72mg daily | ADHD |
| MED_NEURO_STIM_003 | Methylphenidate ER (Ritalin LA) | 10-60mg daily | ADHD |
| MED_NEURO_STIM_004 | Dexmethylphenidate (Focalin/XR) | 2.5-20mg daily (IR) / 5-40mg (XR) | ADHD |
| MED_NEURO_STIM_005 | Amphetamine/Dextroamphetamine IR (Adderall) | 5-40mg daily (BID) | ADHD, Narcolepsy |
| MED_NEURO_STIM_006 | Amphetamine/Dextroamphetamine XR (Adderall XR) | 5-30mg daily | ADHD |
| MED_NEURO_STIM_007 | Lisdexamfetamine (Vyvanse) | 10-70mg daily | ADHD, Binge eating disorder |
| MED_NEURO_STIM_008 | Dextroamphetamine (Dexedrine/Zenzedi) | 5-40mg daily | ADHD, Narcolepsy |

**Subtotal: 8 cards**

---

### Tier 4: Non-Stimulants

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_NONSTIM_001 | Atomoxetine (Strattera) | 40-100mg daily | ADHD (SNRI) |
| MED_NEURO_NONSTIM_002 | Viloxazine (Qelbree) | 100-600mg daily | ADHD |
| MED_NEURO_NONSTIM_003 | Guanfacine ER (Intuniv) | 1-4mg daily | ADHD (alpha-2 agonist) |
| MED_NEURO_NONSTIM_004 | Clonidine ER (Kapvay) | 0.1-0.4mg daily | ADHD (alpha-2 agonist) |

**Subtotal: 4 cards**

---

## SLEEP MEDICATIONS

### Tier 4: Non-Benzodiazepine Hypnotics (Z-drugs)

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_ZDRUG_001 | Zolpidem (Ambien) | 5-10mg HS | Insomnia (sleep onset) |
| MED_NEURO_ZDRUG_002 | Zolpidem ER (Ambien CR) | 6.25-12.5mg HS | Insomnia (onset + maintenance) |
| MED_NEURO_ZDRUG_003 | Eszopiclone (Lunesta) | 1-3mg HS | Insomnia |
| MED_NEURO_ZDRUG_004 | Zaleplon (Sonata) | 5-20mg HS | Insomnia (ultra-short) |

**Subtotal: 4 cards**

---

### Tier 4: Orexin Receptor Antagonists

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_OREX_001 | Suvorexant (Belsomra) | 5-20mg HS | Insomnia |
| MED_NEURO_OREX_002 | Lemborexant (Dayvigo) | 5-10mg HS | Insomnia |
| MED_NEURO_OREX_003 | Daridorexant (Quviviq) | 25-50mg HS | Insomnia |

**Subtotal: 3 cards**

---

### Tier 4: Other Sleep Agents

| Card ID | Card Name | Common Doses | Primary Use |
|---------|-----------|--------------|-------------|
| MED_NEURO_SLEEPOTH_001 | Ramelteon (Rozerem) | 8mg HS | Insomnia (melatonin agonist) |
| MED_NEURO_SLEEPOTH_002 | Doxepin (Silenor) | 3-6mg HS | Insomnia (low-dose TCA) |

**Subtotal: 2 cards**

---

## Summary

| Tier 4 Category | Card Count |
|-----------------|------------|
| **ANTIDEPRESSANTS** | |
| SSRIs | 8 |
| SNRIs | 5 |
| Atypical Antidepressants | 4 |
| Tricyclic Antidepressants | 6 |
| MAOIs | 3 |
| **ANXIOLYTICS** | |
| Benzodiazepines | 8 |
| Non-Benzodiazepine Anxiolytics | 2 |
| **ANTIPSYCHOTICS** | |
| Second-Generation (Atypical) | 13 |
| First-Generation (Typical) | 5 |
| **MOOD STABILIZERS** | |
| Lithium | 1 |
| **ANTI-SEIZURE MEDICATIONS** | |
| Traditional Anticonvulsants | 5 |
| Newer Anticonvulsants | 12 |
| **MIGRAINE MEDICATIONS** | |
| Triptans | 7 |
| Non-Triptan Acute | 5 |
| CGRP Inhibitors (Preventive) | 5 |
| **ADHD MEDICATIONS** | |
| Stimulants | 8 |
| Non-Stimulants | 4 |
| **SLEEP MEDICATIONS** | |
| Z-drugs | 4 |
| Orexin Antagonists | 3 |
| Other Sleep Agents | 2 |
| **TOTAL** | **110 cards** |

---

## Card Naming Convention

**Format**: `MED_NEURO_[SUBCLASS]_[NUMBER]`

**Subclass Abbreviations**:
- `SSRI`, `SNRI`, `ATYP`, `TCA`, `MAOI` = Antidepressant classes
- `BENZO`, `ANXOTH` = Anxiolytics
- `SGA`, `FGA` = Antipsychotics (Second/First Generation)
- `MOOD` = Mood Stabilizers
- `AED`, `AEDN` = Anticonvulsants (traditional/newer)
- `TRIP`, `MIGAC`, `CGRP` = Migraine medications
- `STIM`, `NONSTIM` = ADHD medications
- `ZDRUG`, `OREX`, `SLEEPOTH` = Sleep medications

---

## Notes

1. **Cross-indication use**: Many neuro/psych meds have multiple uses (e.g., gabapentin: seizures, neuropathy, anxiety)
2. **Black box warnings**: SSRIs/SNRIs (suicidality <25yo), antipsychotics (elderly dementia mortality), stimulants (CV risk)
3. **Controlled substances**: Benzodiazepines, stimulants, Z-drugs are Schedule II-IV
4. **Dose titration**: Most neuro/psych meds require slow titration up and tapering down
5. **Drug interactions**: MAOIs require 2-week washout; serotonin syndrome risk with combinations

---

## Clinical Pearls for Card Development

1. **SSRI/SNRI Cards**: Include sexual dysfunction, discontinuation syndrome, serotonin syndrome risk
2. **Benzodiazepine Cards**: Include dependence risk, taper protocols, elderly fall risk
3. **Antipsychotic Cards**: Include metabolic monitoring (weight, glucose, lipids), EPS, QT prolongation
4. **Lithium Cards**: Include level monitoring, thyroid/kidney monitoring, toxicity signs
5. **Anticonvulsant Cards**: Include teratogenicity warnings (especially valproate), rash risk (lamotrigine)
6. **Stimulant Cards**: Include cardiac screening, growth monitoring in children, abuse potential

---

*Version 1.0 | Created: 2024-11-23*
*Source: LIBRARY_TIER_STRUCTURE.md*
